Development of a Drug-Likeness Rule for Natural Products
ISEF · 2018 Translational Medical Science Second Award
Overview
Development of a Drug-likeness Rule for Natural Products Saadh Ahmed Northview High School, Johns Creek , GA, USA In the field of drug discovery, the first steps are crucial to the overall success of developing a marketable drug. Due to this, measures are taken to ensure that only compounds with the highest probability of being drug-like are selected to be taken into the next stages of drug development. During these phases, drug-likeness filters are used to reduce collections of compounds to only those that have the highest drug-like potential. However, it is during these stages that many compounds with excellent capacity of drug-likeness are overlooked. Natural products are often victims of initial screens as they tend to break these established rules, but hold considerable drug-like effects. To combat this issue, this research proposes a new series drug-likeness rules called the Natural Product Drug-likeness Rules. These rules were developed after analysis of a database that contains only drug-like natural compounds. 70 properties for each of the compounds were evaluated for patterns and commonalities within the database. Out of these 70 properties, 5 independent properties were selected for them being shared among 76% of the entire database and compiled into a new rule called the Primary NPDR. Two other variations of Natural Product Drug-likeness Rules were also created and successfully demonstrated high accuracy in drug-like compound selection. The Natural Product Drug-likeness Rules combine quantitative and qualitative screening techniques. These new rules outperform the most common drug-likeness rules when employed against natural products. The Natural Product Drug-likeness Rules have potential to open new opportunities for drug discovery of natural compounds.
Awards (2)
- Second Award of $2,000 $2,000
- National Institute on Drug Abuse, National Institutes of Health & the Friends of NIDA: Third Award of $1,000 $1,000
Competition history
- ISEF 2018
Resources
Related projects
ISEF · 2024
Target-Specific Development of Pseudo Natural Products Through the Combination of Natural Product Fragments
ISEF · 2015
Rethinking Drug Discovery: New Algorithms for Virtual Drug Screening
ISEF · 2021
Novel Evolutionary Artificial Intelligence Methods for De Novo Drug Design
ISEF · 2025
A Novel Computational Generative Model That Identifies Ligands: A Potential Way to Reduce Cost & Time in Identifying Promising Drug Candidates
ISEF · 2023
A Novel Approach to Systemic in silico Drug Discovery Using a Machine Learning-Based Prediction of Binding Affinity
ISEF · 2022
Novel Reinforcement Learning Framework for Synthesizable Drug Optimization
ISEF · 2021
A Novel Computational Approach to Drug Discovery Through Drug Repositioning
ISEF · 2015
MEDI-Profiler: A Computational Classifier that Identifies Determinant Chemical Features and Their Influences on Pharmaceutical Drug Properties
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair